Retour aux projets

18546.1 PFLS-LS

18546.1 PFLS-LS

Résumé

Profiling of new oxytocin receptor agonists for the treatment of anxiety and autism spectrum disorders through a new microdrive-mounted optrode allowing combined electrophysiological and fMRI analyses.

Textes supplémentaires

Abstract

To profile newly developed oxytocin receptor agonists for anxiety and autism spectrum disorders by comparing their actions with those of endogenous oxytocin signaling in relevant brain circuits, we will construct and implement a fMRI compatible microdrive-mounted optrode that allows measurements of effects of optogenetically stimulated release of endogenous oxytocin using simultaneous fMRI scannings and electrophysiological recordings of single unit neuronal activity.

Participants

Thomas Mueggler

Wirtschaftspartner

thomas.mueggler@roche.com

F. Hoffmann-La Roche Ltd Thomas Mueggler Building 73 / Grenzacherstrasse 124 4070 Basel BS CH

Ron Stoop

Kontaktperson

Ron.Stoop@unil.ch

CHUV Centre Hospitalier Universitaire Va Centre for Psychiatric Neuroscience Ron Stoop Hôpital de Cery / Route de Cery 1005 Lausanne VD CH

Détails du projet

Office de recherche
INNOSUISSE
Statut du projet
Abgeschlossen
Type de projet
Forschungsprojekt
Date de début
2015-12-31
Date de fin
2018-12-31
Coûts totaux approuvés
CHF 558114.00
Section
20 Förderbereich Life Sciences
Domaine politique NABS
Industrielle Produktivität und Technologie

Disciplines de recherche

  • T115 Medical technology 100.0%